![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Lantheus
LNTH
Hutchmed (China)
HCM
Workday
WDAY
DexCom
DXCM
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
US Stock MarketDetailed Quotes
SLXN Silexion Therapeutics
- 1.150
- -0.080-6.50%
Close Feb 26 16:00 ET
- 1.140
- -0.010-0.86%
Post 19:57 ET
9.68MMarket Cap-0.06P/E (TTM)
1.210High1.050Low3.51MVolume1.210Open1.230Pre Close4.06MTurnover67.02%Turnover RatioLossP/E (Static)8.41MShares122.01852wk High-2.11P/B6.02MFloat Cap0.57552wk Low--Dividend TTM5.23MShs Float122.013Historical High--Div YieldTTM13.01%Amplitude0.575Historical Low1.157Avg Price1Lot Size
Silexion Therapeutics Stock Forum
Sign in to post a comment
NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY...
29
1
1
🔵Watchlist, FEBRUARY 26,2025, Wednesday. NFA -DrJag8. NOTE: I won’t entertain questions. Do your DD.
NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free c...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free c...
59
13
6
$Silexion Therapeutics (SLXN.US)$ ran 3 x in five minutes
1
1
$Silexion Therapeutics (SLXN.US)$
Wtf Hit the stop loss & up again.
Wtf Hit the stop loss & up again.
7
$Silexion Therapeutics (SLXN.US)$ today can go 1.5?
1
$Silexion Therapeutics (SLXN.US)$
Can Silexion's RNA Therapy Change Pancreatic Cancer Treatment? Key Study Completed
Can Silexion's RNA Therapy Change Pancreatic Cancer Treatment? Key Study Completed
1
$Silexion Therapeutics (SLXN.US)$ Silexion Therapeutics Announces Completion of Initial Study in Orthotopic Pancreatic Cancer Models Evaluating Systemic Administration of SIL-204
3 MINUTES AGO, 8:30 AM EST
VIA GLOBENEWSWIRE
3 MINUTES AGO, 8:30 AM EST
VIA GLOBENEWSWIRE
$Silexion Therapeutics (SLXN.US)$
Silexion Therapeutics Announces Completion of Initial Study in Orthotopic Pancreatic Cancer Models Evaluating Systemic Administration of SIL-204
12 seconds ago, 5:30 AM PST
Via GlobeNewswire
SLXN
Share
Grand Cayman, Cayman Islands, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ:SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today announced...
Silexion Therapeutics Announces Completion of Initial Study in Orthotopic Pancreatic Cancer Models Evaluating Systemic Administration of SIL-204
12 seconds ago, 5:30 AM PST
Via GlobeNewswire
SLXN
Share
Grand Cayman, Cayman Islands, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ:SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today announced...
No comment yet
Trailside22 : shes a beauty AH.![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")